Home

James Rothman

CIK 1380378 · last filed 2023-10-03

James Rothman is a corporate insider who has filed 12 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for CELL, was dated Oct 3, 2023. Across all open-market trades the lifetime net is −$12.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $8.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$7.98M

Companies

5

Total Filings

12

Lifetime Open-Market Net

-$12.92M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Bruker Cellular Analysis, Inc. (CELL) Delisted Director 0 $1.00 $0 $0 1 2023-10-03
Bruker Cellular Analysis, Inc. (BLI) Delisted Director 163,810 $1.20 $196.6K -$12.92M 5 2022-08-01
MRNA Director — $59.49 — $0 2 2009-05-21
INGN Director — $6.56 — $0 1 2008-08-13
ACA 55,080 $144.88 $7.98M $6.3K 1 2007-08-02

Recent Filings

12 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-10-03 Bruker Cellular Analysis, Inc. (CELL) Delisted Disp (D) −118,810 $0 EDGAR
2023-08-17 — Notice (144) −11,099 -$10.5K EDGAR
2023-08-16 — Notice (144) −33,901 -$13.5K EDGAR
2022-08-01 Bruker Cellular Analysis, Inc. (BLI) Delisted Grant (A) +19,565 $0 EDGAR
2021-11-10 Bruker Cellular Analysis, Inc. (BLI) Delisted Buy (P) +4,000 $97.4K EDGAR
2021-05-18 Bruker Cellular Analysis, Inc. (BLI) Delisted Grant (A) +1,400 $0 EDGAR
2021-03-09 Bruker Cellular Analysis, Inc. (BLI) Delisted Sell (S) −140,000 -$7.38M EDGAR
2021-03-05 Bruker Cellular Analysis, Inc. (BLI) Delisted Mixed +278,845 -$4.69M EDGAR
2009-05-21 MRNA Grant (A) — $0 EDGAR
2008-08-13 INGN Grant (A) — $0 EDGAR
Showing 1–10 of 12
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.